NCT00618683

Brief Summary

The purpose of this study is to determine/identify what mechanisms/factors are involved with regard to AV nodal reentrant tachycardia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2004

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 25, 2004

Completed
3.9 years until next milestone

First Submitted

Initial submission to the registry

February 7, 2008

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 20, 2008

Completed
11.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 21, 2020

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 12, 2021

Completed
Last Updated

May 10, 2024

Status Verified

May 1, 2024

Enrollment Period

15.8 years

First QC Date

February 7, 2008

Last Update Submit

May 9, 2024

Conditions

Tachycardia, Atrioventricular Nodal Reentry

Keywords

AVNRTAtrioventricularnodal reentrant circuitnodal reentrant tachycardiaParoxysmal supraventricular tachycardia

Outcome Measures

Primary Outcomes (1)

  • raise the frequency of success to more than 98%

    unk

Study Arms (1)

Study Arm

OTHER

Mapping and Ablation

Procedure: Cardiac Invasive Electrophysiological Study

Interventions

Cardiac Invasive Electrophysiological StudyPROCEDURE

Mapping and localizing of the components of the reentrant circuit as part of the Electrophysiological Study

Study Arm

Eligibility Criteria

Age16 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Ages 16-80
  • At least one documented episode of AV nodal reentrant tachycardia
  • Patient scheduled for electrophysiology study and catheter ablation for supraventricular tachycardia

You may not qualify if:

  • Ages \< 16 or \> 80
  • Medical condition significantly increasing risk of extending procedure time or X-ray exposure
  • Pregnancy
  • Prior ablation with radiation exposure \>2 hours
  • Electrophysiology study performed without sedation or anesthesia
  • Unavailable for follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, 73104, United States

Location

MeSH Terms

Conditions

Tachycardia, Atrioventricular Nodal ReentryTachycardia, Ventricular

Condition Hierarchy (Ancestors)

Tachycardia, ReciprocatingTachycardiaArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Stavros Stavrakis, MD

    University of Oklahoma

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2008

First Posted

February 20, 2008

Study Start

March 25, 2004

Primary Completion

January 21, 2020

Study Completion

January 12, 2021

Last Updated

May 10, 2024

Record last verified: 2024-05

Locations

US(1)